Advertisement
Canada markets close in 3 hours 19 minutes
  • S&P/TSX

    21,825.70
    -186.02 (-0.85%)
     
  • S&P 500

    5,050.18
    -20.37 (-0.40%)
     
  • DOW

    38,346.76
    -156.93 (-0.41%)
     
  • CAD/USD

    0.7289
    -0.0032 (-0.43%)
     
  • CRUDE OIL

    82.71
    -0.65 (-0.78%)
     
  • Bitcoin CAD

    88,809.98
    -2,626.73 (-2.87%)
     
  • CMC Crypto 200

    1,397.45
    -26.65 (-1.87%)
     
  • GOLD FUTURES

    2,336.60
    -5.50 (-0.23%)
     
  • RUSSELL 2000

    1,985.46
    -17.18 (-0.86%)
     
  • 10-Yr Bond

    4.6480
    +0.0500 (+1.09%)
     
  • NASDAQ

    15,652.18
    -44.46 (-0.28%)
     
  • VOLATILITY

    16.22
    +0.53 (+3.38%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6819
    -0.0017 (-0.25%)
     

European shares rise on vaccine hopes, China data; Brexit talks eyed

(For a live blog on European stocks, type LIVE/ in an Eikon news window)

Dec 1 (Reuters) - European shares on Tuesday made a positive start to December, with optimism around a coronavirus vaccine strengthening the case for an economic recovery and priming stocks for an extension of November's record-breaking gains.

After a day's dip, when investors took some profits at the end of a spectacular month, the pan-European STOXX 600 index was back in the black, up 0.3%.

The index ended November with gains of nearly 14%.

Further bolstering sentiment, a business survey echoed official numbers from a day earlier which showed robust growth in China's factory activity. Similar data from Europe is due later in the day.

Uncertainties around a Brexit trade deal, however, kept gains in check. The European Union will launch contingency measures on Wednesday or Thursday, if it is unable to reach an agreement by then with Britain, a senior EU diplomat said on Monday. (Reporting by Susan Mathew in Bengaluru; Editing by Shounak Dasgupta)